Clinical Trials
2 trialsPhase 1/2 × Unresectable Locally Advanced or Metastatic Solid Tumors × Other solid neoplasm × Clear all
NCT06974812 2026-01-29
IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2 Recruiting
NCT06682611 2024-11-12
Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.
Shanghai Runshi Pharmaceutical Technology Co., Ltd
Phase 1/2 Not yet recruiting